PPT-OTTR’s GvHD Tools: ExtraCorporeal
Author : lauren | Published Date : 2022-06-14
Photopheresis ECP Carrie Barnhart RN BSN CHTC BMTCN At the completion of this session you will Learn how OTTRBMT solution currently tracks and documents standardized
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "OTTR’s GvHD Tools: ExtraCorporeal" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
OTTR’s GvHD Tools: ExtraCorporeal: Transcript
Photopheresis ECP Carrie Barnhart RN BSN CHTC BMTCN At the completion of this session you will Learn how OTTRBMT solution currently tracks and documents standardized GraftversusHost Disease . Falcon Hypersonic Technology Vehicle. (HTV-2) Test. Advanced Technologies. Enabling Long-Duration Hypersonic Flight . for Prompt Global Reach. Rob Davies, USARPAC . Frank . Highsmith, USPACOM. Chris . vs. Host . Disease, Photopheresis. . and the Future…... BSBMT. 2 November 2016. Peter Taylor . Consultant . Haematologist. ,. Honorary Senior Lecturer, University of Sheffield, UK. Director of Photopheresis, . Falcon Hypersonic Technology Vehicle. (HTV-2) Test. Advanced Technologies. Enabling Long-Duration Hypersonic Flight . for Prompt Global Reach. Rob Davies, USARPAC . Frank . Highsmith, USPACOM. Chris . Surfactant Replacement. Composition. Phospholipids (90%). phosphatidylcholine (PC) (85%) - dipalmitoyl phosphatidylcholine (DPPC) (60%). Phosphatidylglycerol (PG). Phosphatidylinositol (PI). Cholesterol. Transitioning Customers to OTTR . 7. Customer Experience. Quality . Transitioning Customers to OTTR 7. Over half of all our customers have moved to OTTR7!!!. New Customers. Existing Customers. Children’s . CONFIDENTIAL Page 8 of RTCy ruxolitinib 33Acute graft-versus-host disease treatment 33Dose regimen and modification 34Drug supplies 35Other study treatments 35Concomitant medications 35Permitte 1 Transplant Events -8 -1 0 1mo 3mo 6mo Conditioning TransplantMucositisOrgan toxicity (VOD)Acute GVHD Chronic GVHD I Definition Graft-versus-host disease (GVHD) is the most common complication of allogeneic hematopoietic stem cell transplantation (HSCT). In HSCT, the patients bone marrow is destroyed with che Information for young people with cancer, and parents of a child or young person with cancer, having a donor (allogeneic) stem cell transplantGraft versus host disease (GvHD) www.cclg.org.ukstem cell Weill Cornell Medicine is an academic medical center that provides exemplary care for our patients. OurDivisionofColonandRectal Surgeryincludesthe nation’sleadingsurgeonsforcolonandrectal surgical 1 Transplant Events Day-8 0 1mo 3mo 6mo Conditioning HSCTMucositisOrgan toxicity (VOD)Acute GVHD Chronic GVHD Bacterial Docs-Tools is an online software and teaching marketplace. They work to make quality education tools accessible to all students, regardless of their background or location. Graft vs Host Disease. Rene Romero, M.D. and . Matthew Hsieh. December , 2020. Graft vs Host Disease. Graft vs Host Disease Definition: Donor bone marrow cells initiate an immune response and subsequent injury to recipient cells, tissue or organs.. Def: the administration of hematopoietic stem cells from any source (ex: bone marrow, peripheral blood, umbilical cord blood) to reconstitute the bone marrow.. The Nobel Prize, 1990. E. Donnall Thomas .
Download Document
Here is the link to download the presentation.
"OTTR’s GvHD Tools: ExtraCorporeal"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents